68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO) (NCT04139395) | Clinical Trial Compass
WithdrawnPhase 3
68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)
Stopped: Not feasible at this time.
United States0Started 2019-01-15
Plain-language summary
This is a Phase III study to evaluate 68Ga Citrate PET/MRI for detection of origin of fever of unknown origin.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient is \>/=18 years old at the time of the scan.
* Patient with diagnosis of FUO.
* Patient is capable of complying with study procedures.
* Patient can remain still for duration of imaging procedure.
* Able to provide written consent.
Exclusion Criteria:
* Patient is pregnant or nursing.
* Metallic implants (contraindicated for MRI).
* History of renal insufficiency (only for MRI contrast administration).
* Inability to lie still for the entire imaging time.
* Inability to complete the needed investigational and standard of care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.).
* Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the investigator, may significantly interfere with study compliance.
* Known allergy, hypersensitivity, or intolerance to the investigational product or its excipients.